September 21, 2020
The U.S. surpasses 200,000 COVID-19 deaths, more than the U.S. battle deaths from five wars combined. Trump gives himself an “A+” for his pandemic handling, with the caveat that on public relations he deserves a “D” because of “fake news.” The Lancet changes its editorial policy after the hydroxychloroquine study retraction, a rare institutional acknowledgment that the quality-control failures at prestigious medical journals have real-world consequences for treatment decisions. More than 150 nations join the WHO’s global vaccine plan, but the U.S. and China remain absent, underscoring the geopolitical fault lines that will determine who gets vaccinated first.
Britain imposes six-month curbs against a second wave, with Boris Johnson ordering pubs and restaurants to close at 10 p.m., abandoning the “back to work” drive of summer. Scientists warn of signs of an “October vaccine surprise,” alarmed that the Trump administration might pressure the FDA to authorize a vaccine before the election in ways that further erode public trust. The Conversation runs an explainer on how clinical trials test COVID-19 vaccines, part of a broader push by scientific outlets to educate the public on the process at a moment when its integrity is in question. Black doctors create their own task force to independently evaluate vaccine safety, a response to the community’s well-founded skepticism of the medical establishment.











:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/archetype/NP7XWBE54JGIBJ63LEFE7OKFQQ.jpg)

